Verena Staedtke Selected Research

Mebendazole (Anti-Worm)

1/2021	Mebendazole and temozolomide in patients with newly diagnosed high-grade gliomas: results of a phase 1 clinical trial.
1/2020	Preventative Effect of Mebendazole against Malignancies in Neurofibromatosis 1.
10/2016	Mebendazole and a non-steroidal anti-inflammatory combine to reduce tumor initiation in a colon cancer preclinical model.
8/2015	Brain Penetration and Efficacy of Different Mebendazole Polymorphs in a Mouse Brain Tumor Model.
4/2015	Effective treatment of diverse medulloblastoma models with mebendazole and its impact on tumor angiogenesis.
9/2011	Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Verena Staedtke Research Topics

Disease

17	Neoplasms (Cancer) 01/2022 - 07/2010
7	Brain Neoplasms (Brain Tumor) 01/2022 - 09/2011
5	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 06/2011
5	Glioma (Gliomas) 01/2021 - 09/2011
4	Medulloblastoma 08/2015 - 07/2010
3	Neurofibromatosis 1 (Neurofibromatosis Type I) 01/2020 - 01/2017
3	Cytokine Release Syndrome 01/2020 - 12/2018
2	Neurofibrosarcoma (MPNST) 01/2020 - 01/2019
2	Infections 12/2018 - 12/2013
1	Respiratory Tract Infections (Respiratory Tract Infection) 11/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020
1	COVID-19 01/2020
1	Bacterial Infections (Bacterial Infection) 01/2018
1	Brain Abscess (Abscess, Brain) 01/2018
1	Tuberous Sclerosis (Bourneville's Disease) 01/2017
1	Epilepsy (Aura) 01/2017
1	Sarcoma (Soft Tissue Sarcoma) 01/2017
1	Seizures (Absence Seizure) 01/2017
1	Sturge-Weber Syndrome (Sturge-Kalischer-Weber Syndrome) 01/2017
1	Neurocutaneous Syndromes (Phakomatoses) 01/2017
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2017
1	Colonic Neoplasms (Colon Cancer) 10/2016
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 10/2016
1	Adenoma (Adenomas) 10/2016
1	Polyps 10/2016
1	Edema (Dropsy) 03/2015
1	Hypoxia (Hypoxemia) 03/2015
1	Enterobiasis 09/2011
1	Parasitic Diseases (Parasitic Disease) 09/2011

Drug/Important Bio-Agent (IBA)

6	Mebendazole (Anti-Worm)FDA Link 01/2021 - 09/2011
3	Pharmaceutical PreparationsIBA 01/2021 - 06/2011
2	Contrast MediaIBA 01/2022 - 01/2018
2	AntibodiesIBA 01/2021 - 12/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2018 - 03/2015
2	Antiparasitic Agents (Antiparasitics)IBA 08/2015 - 09/2011
1	Dichlorodiphenyl Dichloroethylene (DDE)IBA 01/2022
1	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2022
1	alpha-1 Adrenergic Receptors (alpha 1 Adrenergic Receptor)IBA 11/2021
1	Temozolomide (Temodar)FDA LinkGeneric 01/2021
1	AnthelminticsIBA 01/2021
1	Guanosine Triphosphate (GTP)IBA 01/2020
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2020
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2020
1	axicabtagene ciloleucelIBA 01/2020
1	Adrenergic Antagonists (Antiadrenergic Agents)IBA 01/2020
1	ras ProteinsIBA 01/2019
1	Neurofibromin 1 (Neurofibromin)IBA 01/2019
1	alpha-Methyltyrosine (Metirosine)FDA Link 12/2018
1	CatecholaminesIBA 12/2018
1	Ampicillin (Omnipen)FDA LinkGeneric 01/2018
1	Dextrans (Dextran)FDA Link 01/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2017
1	GelatinIBA 04/2017
1	Peptides (Polypeptides)IBA 01/2017
1	HydrogelsIBA 01/2017
1	Sirolimus (Rapamycin)FDA Link 01/2017
1	trans-sodium crocetinate (crocetin)IBA 01/2017
1	Sulindac (Copal)FDA LinkGeneric 10/2016
1	Drug CombinationsIBA 10/2016
1	Investigational DrugsIBA 08/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	ElacridarIBA 08/2015
1	TabletsIBA 08/2015
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 04/2015
1	HhAntag691IBA 04/2015
1	Phosphotransferases (Kinase)IBA 04/2015
1	Proteins (Proteins, Gene)FDA Link 01/2013
1	podocalyxinIBA 01/2013
1	Otx Transcription FactorsIBA 11/2012
1	benzimidazoleIBA 09/2011
1	FenbendazoleIBA 09/2011
1	Drug CarriersIBA 01/2011
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 07/2010
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 07/2010

Therapy/Procedure

12	Therapeutics 01/2022 - 07/2010
2	Immunotherapy 12/2018 - 08/2016
2	Drug Therapy (Chemotherapy) 01/2017 - 08/2016
1	Precision Medicine 01/2018
1	Intraperitoneal Injections 01/2018
1	Aftercare (After-Treatment) 12/2013